Blair Landon (@blair_landon15) 's Twitter Profile
Blair Landon

@blair_landon15

ID: 208190032

calendar_today26-10-2010 20:28:55

461 Tweet

125 Followers

170 Following

Elsa Anagnostou (@valsamoa) 's Twitter Profile Photo

#KRAS alert! Over the past 4 years, a multi-disciplinary team from Johns Hopkins Kimmel Cancer Center Vanderbilt-Ingram Cancer Center Dana-Farber Memorial Sloan Kettering Cancer Center & Amgen 🧪🔬🧬 has been studying the distribution and co-mutations of KRAS, NRAS and HRAS mutant #cancers under the auspices of AACR project #GENIE. Read the 🧵

#KRAS alert! Over the past 4 years, a multi-disciplinary team from <a href="/hopkinskimmel/">Johns Hopkins Kimmel Cancer Center</a> <a href="/VUMC_Cancer/">Vanderbilt-Ingram Cancer Center</a> <a href="/DanaFarber/">Dana-Farber</a> <a href="/MSKCancerCenter/">Memorial Sloan Kettering Cancer Center</a> &amp; <a href="/Amgen/">Amgen 🧪🔬🧬</a> has been studying the distribution and co-mutations of KRAS, NRAS and HRAS mutant #cancers under the auspices of <a href="/AACR/">AACR</a> project #GENIE. Read the 🧵
Elsa Anagnostou (@valsamoa) 's Twitter Profile Photo

Congrats to our stellar graduate student Blair Landon for her scholar-in-training award for her #AACR23 abstract on liquid biopsy analyses for patients with #immunotherapy treated esophageal cancer! CMM JHU Molecular OncologyLab Johns Hopkins Thoracic Oncology AACR #proudmentor #WomenInScience

Congrats to our stellar graduate student <a href="/Blair_Landon15/">Blair Landon</a> for her scholar-in-training award for her #AACR23 abstract on liquid biopsy analyses for patients with #immunotherapy treated esophageal cancer! <a href="/CMM_JHU/">CMM JHU</a> <a href="/MolecularOncLab/">Molecular OncologyLab</a> <a href="/HopkinsThoracic/">Johns Hopkins Thoracic Oncology</a> <a href="/AACR/">AACR</a> #proudmentor #WomenInScience
Elsa Anagnostou (@valsamoa) 's Twitter Profile Photo

#AACR23, Molecular OncologyLab #1/7: CMM JHU student extraordinaire Blair Landon will present her work on ctDNA analyses in predicting tumor regression with neoadjuvant immuno-chemotherapy for patients with operable esophagogastric cancer. Johns Hopkins Kimmel Cancer Center Johns Hopkins Thoracic Oncology

#AACR23, <a href="/MolecularOncLab/">Molecular OncologyLab</a> #1/7: <a href="/CMM_JHU/">CMM JHU</a> student extraordinaire <a href="/Blair_Landon15/">Blair Landon</a> will present her work on ctDNA analyses in predicting tumor regression with neoadjuvant immuno-chemotherapy for patients with operable esophagogastric cancer.  <a href="/hopkinskimmel/">Johns Hopkins Kimmel Cancer Center</a> <a href="/HopkinsThoracic/">Johns Hopkins Thoracic Oncology</a>
Elsa Anagnostou (@valsamoa) 's Twitter Profile Photo

Cannot think of a better way to celebrate our Nature Medicine #liquidbiopsy study than with the Molecular OncologyLab family (wet lab part pictured 😀)! Fortunate to be surrounded by such talented & driven scientists! Lavanya Sivapalan Maria Fatteh Mimi Najjar, MD Blair Landon + more

Cannot think of a better way to celebrate our <a href="/NatureMedicine/">Nature Medicine</a> #liquidbiopsy study than with the <a href="/MolecularOncLab/">Molecular OncologyLab</a> family (wet lab part pictured 😀)! Fortunate to be surrounded by such talented &amp; driven scientists! <a href="/LavanyaSivapal1/">Lavanya Sivapalan</a> <a href="/MariaFatteh/">Maria Fatteh</a> <a href="/mimi_najjar/">Mimi Najjar, MD</a> <a href="/Blair_Landon15/">Blair Landon</a> + more
Elsa Anagnostou (@valsamoa) 's Twitter Profile Photo

So fortunate to celebrate the holiday season with the Molecular OncologyLab! Cannot think of a more dynamic, creative and more importantly good-hearted group of people🙏

So fortunate to celebrate the holiday season with the <a href="/MolecularOncLab/">Molecular OncologyLab</a>! Cannot think of a more dynamic, creative and more importantly good-hearted group of people🙏
Hopkins Med News (@hopkinsmednews) 's Twitter Profile Photo

Monitoring DNA shed by tumors into the bloodstream could indicate gastroesophageal cancer response to treatment: study led by Johns Hopkins Kimmel Cancer Center investigators. bit.ly/4aaRtBU

Nature Medicine (@naturemedicine) 's Twitter Profile Photo

In a phase 1b trial in #GastroesophagealCancer, neoadjuvant nivolumab or nivolumab/relatlimab prior chemoradiotherapy were well tolerated and liquid biopsy analyses show that undetectable ctDNA was associated with longer survival Elsa Anagnostou Vincent Lam nature.com/articles/s4159…

Elsa Anagnostou (@valsamoa) 's Twitter Profile Photo

The Molecular OncologyLab is on the way to #AACR24! Hope to see everyone at our presentations & poster sessions covering #liquidbiopsies #cancergenomics, #Immunotherapy #PrecisionOncology! + celebrating 3⃣ scholar-in-training awards! AACR Blair Landon Lavanya Sivapalan Maria Fatteh

The <a href="/MolecularOncLab/">Molecular OncologyLab</a> is on the way to #AACR24! Hope to see everyone at our presentations &amp; poster sessions covering #liquidbiopsies #cancergenomics, #Immunotherapy #PrecisionOncology! + celebrating 3⃣ scholar-in-training awards! <a href="/AACR/">AACR</a> <a href="/Blair_Landon15/">Blair Landon</a> <a href="/LavanyaSivapal1/">Lavanya Sivapalan</a> <a href="/MariaFatteh/">Maria Fatteh</a>
Nature Medicine (@naturemedicine) 's Twitter Profile Photo

At the #AACR24 #LiquidBiopsies session? Check out this phase 1b trial of neoadjuvant #immunotherapy in esophageal/GEJ cancer led by speaker Elsa Anagnostou. Results show that undetectable ctDNA was associated with longer survival Johns Hopkins Kimmel Cancer Center Vincent Lam nature.com/articles/s4159…

LUNGevity Foundation (@lungevity) 's Twitter Profile Photo

Analysis of responders/non-responders to epigenetic priming of metastatic #NSCLC after progression on immunotx -> More antigen presentation & inflammatory response in responders. Use of epigenetic priming to reverse immunotx resistance? Blair Landon Dr. Julie Brahmer #AACR24

Analysis of responders/non-responders to epigenetic priming of metastatic #NSCLC after progression on immunotx -&gt; More antigen presentation &amp; inflammatory response in responders.  Use of epigenetic priming to reverse immunotx resistance? <a href="/Blair_Landon15/">Blair Landon</a> <a href="/JulieBrahmer/">Dr. Julie Brahmer</a> #AACR24
Elsa Anagnostou (@valsamoa) 's Twitter Profile Photo

Last #AACR24 presentation from Molecular OncologyLab happening now in the poster session! Blair Landon our talented CMM JHU grad student seconds her mini-symposium presentation with more evidence of TME reshaping and induction of inflammatory responses with epigenetic tx. AACR

Last #AACR24 presentation from <a href="/MolecularOncLab/">Molecular OncologyLab</a> happening now in the poster session! <a href="/Blair_Landon15/">Blair Landon</a> our talented <a href="/CMM_JHU/">CMM JHU</a> grad student seconds her mini-symposium presentation with more evidence of TME reshaping and induction of inflammatory responses with epigenetic tx. <a href="/AACR/">AACR</a>